Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,327 | 154 | 92.2% |
| Travel and Lodging | $221.89 | 1 | 4.7% |
| Gift | $142.87 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $619.41 | 12 | $0 (2024) |
| Alcon Laboratories Inc | $598.34 | 6 | $0 (2018) |
| ABBVIE INC. | $507.59 | 19 | $0 (2024) |
| Sight Sciences, Inc. | $419.73 | 17 | $0 (2021) |
| BIOTISSUE HOLDINGS INC. | $415.31 | 3 | $0 (2024) |
| Amgen Inc. | $320.76 | 12 | $0 (2024) |
| Glaukos Corporation | $294.19 | 7 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $257.55 | 7 | $0 (2024) |
| Allergan, Inc. | $163.24 | 12 | $0 (2021) |
| Horizon Therapeutics plc | $149.82 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,201 | 35 | Amgen Inc. ($320.76) |
| 2023 | $856.52 | 24 | AbbVie Inc. ($246.03) |
| 2022 | $352.84 | 12 | Alcon Vision LLC ($268.56) |
| 2021 | $517.63 | 27 | Allergan, Inc. ($112.44) |
| 2020 | $201.19 | 11 | Aerie Pharmaceuticals, Inc. ($42.26) |
| 2019 | $424.30 | 18 | Sight Sciences, Inc. ($223.15) |
| 2018 | $782.50 | 18 | Alcon Laboratories Inc ($445.45) |
| 2017 | $355.65 | 12 | Alcon Laboratories Inc ($152.89) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: EYE CARE | ||||||
| 12/12/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Ophthalmology | ||||||
| 10/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/01/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Ophthalmology | ||||||
| 09/02/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $93.75 | General |
| 08/29/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Optics | ||||||
| 08/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $195.00 | General |
| 07/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: EYE CARE | ||||||
| 07/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Ophthalmology | ||||||
| 06/26/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: EYE CARE | ||||||
| 06/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: EYE CARE | ||||||
| 05/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: EYE CARE | ||||||
| 05/03/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 04/26/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 746 | 1,099 | $388,534 | $202,371 |
| 2022 | 15 | 643 | 841 | $257,192 | $94,667 |
| 2021 | 13 | 875 | 1,128 | $446,341 | $98,860 |
| 2020 | 12 | 544 | 599 | $149,886 | $35,598 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 230 | 380 | $251,129 | $129,178 | 51.4% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 70 | 101 | $100,851 | $48,089 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $12,931 | $8,285 | 64.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 130 | 241 | $6,289 | $4,748 | 75.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 63 | $5,412 | $3,852 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 46 | $5,875 | $3,730 | 63.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 69 | 102 | $2,999 | $2,301 | 76.7% |
| 92134 | Imaging of retina | Office | 2023 | 59 | 62 | $2,357 | $1,673 | 71.0% |
| 92025 | Ct scan of cornea | Office | 2023 | 12 | 12 | $404.64 | $290.84 | 71.9% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 11 | 11 | $285.58 | $223.89 | 78.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 90 | 148 | $146,158 | $53,470 | 36.6% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 18 | 25 | $35,456 | $11,671 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $18,345 | $8,214 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 95 | $15,173 | $6,935 | 45.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 86 | 157 | $7,593 | $3,106 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 37 | $3,579 | $2,479 | 69.3% |
| 92250 | Photography of the retina | Office | 2022 | 88 | 90 | $13,765 | $2,076 | 15.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 25 | 25 | $5,425 | $2,061 | 38.0% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 33 | 69 | $2,760 | $1,546 | 56.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 21 | 21 | $2,970 | $1,055 | 35.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 17 | 18 | $1,777 | $759.20 | 42.7% |
| 92134 | Imaging of retina | Office | 2022 | 20 | 21 | $859.26 | $609.33 | 70.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 15 | 15 | $1,031 | $347.95 | 33.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 16 | 17 | $1,261 | $226.35 | 18.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 19 | 19 | $1,042 | $110.64 | 10.6% |
About Dr. Sandeep Bhatia, M.D
Dr. Sandeep Bhatia, M.D is a Ophthalmology healthcare provider based in Jenks, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003034927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Bhatia, M.D has received a total of $4,692 in payments from pharmaceutical and medical device companies, with $1,201 received in 2024. These payments were reported across 157 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,327).
As a Medicare-enrolled provider, Bhatia has provided services to 2,808 Medicare beneficiaries, totaling 3,667 services with total Medicare billing of $431,497. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Jenks, OK
- Active Since 04/23/2007
- Last Updated 05/16/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1003034927
Products in Payments
- DURYSTA (Drug) $375.26
- TEPEZZA (Biological) $320.76
- OMNI (Device) $262.08
- LUMIGAN (Drug) $200.86
- HYDRUS Microstent (Device) $180.84
- ARGOS (Device) $155.39
- TEPEZZA (Drug) $149.82
- Luxor (Device) $142.87
- Tecnis IOL (Device) $137.48
- iDose (Device) $136.29
- PROKERA (Device) $126.56
- LENSAR LASER SYSTEM (Device) $123.28
- rocklatan (Drug) $116.46
- CyPass (Device) $116.08
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $103.84
- OMNI Surgical System (Device) $100.26
- ORA (Device) $92.54
- VYZULTA (Drug) $83.96
- Centurion (Device) $82.53
- XDEMVY (Drug) $79.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.